Mainz Biomed Launches Corporate Health Program in Germany for ColoAlert
Patient Access Initiative Addresses €1 Billion Annual Market in Germany Patient Access Initiative Addresses €1 Billion Annual Market in Germany...…
6,435€
-1,53%
Echtzeit-Aktienkurs Mainz Biomed N.V.
Bid:
Ask:
Nachrichten zur Mainz Biomed N.V. Aktie
Mainz Biomed Provides Year-End 2022 Corporate Review
BERKELEY, US and MAINZ, Germany , Jan. 03, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed”…